You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華納藥廠(688799.SH):收到關於泮托拉唑鈉腸溶片的藥品補充申請批准通知書
格隆匯 05-29 16:33

格隆匯5月29日丨華納藥廠(688799.SH)公佈,近日,公司收到國家藥品監督管理局核准簽發的關於泮托拉唑鈉腸溶片的《藥品補充申請批准通知書》。

泮托拉唑鈉腸溶片是第三代新型質子泵抑制劑,主要用來治療十二指腸潰瘍、胃潰瘍、中、重度反流性食管炎,與克拉黴素和阿莫西林,或克拉黴素和甲硝唑,或阿莫西林和甲硝唑配伍用能夠根除幽門螺桿菌感染。

根據國家相關政策,通過仿製藥一致性評價的藥品品種在醫保支付及醫療機構採購等領域將獲得更大的支持力度。公司的泮托拉唑鈉腸溶片通過仿製藥質量和療效一致性評價將有利於該產品未來的市場銷售和市場競爭。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account